SARS-CoV-2 studies: Only neutralizing antibodies allow conclusions to be drawn about protection against new infections
MedicalXpress Breaking News-and-Events | Mar 22, 2023
SARS-CoV-2 infection weakens immune-cell response to vaccination, suggests study
MedicalXpress Breaking News-and-Events | Mar 22, 2023
Study identifies the human genes enabling SARS-CoV-2 infection
MedicalXpress Breaking News-and-Events | Mar 18, 2023
Malfunctioning immune cell behavior could be drug target in long COVID
MedicalXpress Breaking News-and-Events | Mar 18, 2023
Study finds COVID-19 pandemic has long-lasting effects on adolescent mental health and substance use
MedicalXpress Breaking News-and-Events | Mar 16, 2023
New antimalarial more effective than current treatment, but no improvement in adverse birth outcomes
MedicalXpress Breaking News-and-Events | Mar 15, 2023
Who is most at risk for long COVID?
MedicalXpress Breaking News-and-Events | Mar 11, 2023
Long COVID linked to air pollution exposure in young adults, says new study
MedicalXpress Breaking News-and-Events | Mar 11, 2023
A new class of drugs could prevent resistant COVID-19 variants, study finds
MedicalXpress Breaking News-and-Events | Mar 10, 2023
First nasal monoclonal antibody treatment for COVID-19 shows promise for treating virus, other diseases
MedicalXpress Breaking News-and-Events | Mar 10, 2023